Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based

Ashok Kumar Das1, Sanjay Kalra2, Krishnakumar B3

  • 1Department of Endocrinology & Medicine, Pondicherry Institute of Medical Sciences, Puducherry, India.

Insights

During the COVID-19 pandemic, experts recommend vigilance for cardiometabolic conditions like diabetes and hypertension due to poor outcomes. They also proposed resource-saving strategies to manage healthcare constraints.

Area of Science:

  • Cardiology
  • Endocrinology
  • Infectious Diseases

Background:

  • The COVID-19 pandemic presents significant healthcare challenges, exacerbated by resource limitations.
  • Cardiometabolic disorders, including diabetes and hypertension, are linked to adverse outcomes in COVID-19 patients.
  • Endocrine and cardiology vigilance is crucial for managing patients during this evolving pandemic.

Purpose of the Study:

  • To provide expert opinion on endocrine and cardiology vigilance during the COVID-19 pandemic.
  • To propose resource husbandry recommendations to address healthcare constraints.
  • To guide the management of cardiometabolic conditions amidst the pandemic.

Main Methods:

  • Virtual discussions among clinical experts, including endocrinologists, consultant physicians, and cardiologists from India.
  • Review of existing literature on COVID-19 and cardiometabolic disorders.
  • Formulation of expert-based clinical practice recommendations.

Main Results:

  • Clinical practice-based opinions for managing diabetes mellitus and hypertension during COVID-19.
  • Emphasis on increased caution and precautions for individuals with cardiometabolic conditions.
  • Development of affordable and accessible solutions for resource-constrained situations.

Conclusions:

  • Expert opinions serve as a reference for clinicians managing diabetes and cardiovascular disease during the pandemic.
  • Highlights the importance of proactive management of cardiometabolic health in the context of COVID-19.
  • Provides practical strategies for resource management in healthcare settings.
Abstract

Related Concept Videos

Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
168
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
133
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
142
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
176
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
100
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
129